Gry Grønli had an ePresentation from a single centre study on cerebral venous thrombosis from Oslo University Hospital. PhD student Anna T. Lambert presented data from the pilot study of NOR-FIB at an oral session and Anne Hege Aamodt presented data with atrial fibrillation in NOR-TEST study.
Both NOR-FIB and NOR-TEST were selected for the highlight session of the congress. Next year the congress is in Oslo and a lot of preparation for the congress was done in Lisbon both by the local organising committee and by the Norwegian Neurological Association which Anne Hege Aamodt is the president of. You can find more information on the EAN2018 here: https://www.ean.org/oslo2019/
(click to enlarge images)
Gry Grønli had an ePresentation from a single centre study on cerebral venous thrombosis from Oslo University Hospital.
PhD student Anna T. Lambert presented data from the pilot study of NOR-FIB at an oral session
From PhD student Anna T. Lambert's presentation
Anne Hege Aamodt presented data with atrial fibrillation in NOR-TEST study
Both NOR-FIB and NOR-TEST were selected for the highlight session of the congress.
Next year the congress is in Oslo and a lot of preparation for the congress was done in Lisbon both by the local organising committee and by the Norwegian Neurological Association which Anne Hege Aamodt is the president of.
Rifino N, Aamodt AH, Wiedmann M, Kramer M, Becker J, Guey S, Acerbi F, Herve D, Bersano A(2025) The Spectrum of Headaches in Moyamoya Angiopathy: From Mechanisms to Management Strategies-A Consensus Review From the NEUROVASC Working Group Eur J Neurol, 32(10), e70316 DOI 10.1111/ene.70316, PubMed 41039799
Skattør TH, Bjørnerud A, Nome T, Bakke KM, Enriquez BA, Digernes I, Offersen CM, Beyer MK, Ringstad G, Aamodt AH(2025) Predicting lesion reversal in acute cerebral ischaemia via apparent diffusion coefficient threshold on diffusion-weighted MRI Eur Radiol(in press) DOI 10.1007/s00330-025-12014-0, PubMed 41023466
Øie LR, Wergeland T, Salvesen Ø, Gravdahl GRB, Aschehoug I, Gulati S, Bj Rk MH, Lundqvist C, Alstadhaug KBR, Winsvold BS, Aamodt AH, Larsen IC, B E MG, Braschinsky M, Müller B, Vetvik KGT, Müller KI, Aaseth K, Khanevski AN, Øvrevik AB, Vegrim HM, Lindroos J, Eid K, Engstrand H, Bezgal Bet al.(2025) Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial Lancet Neurol, 24(10), 817-827 DOI 10.1016/S1474-4422(25)00269-8, PubMed 40975098